Irish journal of medical science · 2009
First Irish birth following IVF therapy using antagonist protocol.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mocanu E V, Kondaveeti N, Kelly J, Hennelly B, Burke L, Hughes C
Аннотация
BACKGROUND: During in vitro fertilization (IVF), the prevention of a premature LH surge was traditionally achieved using a gonadotrophin releasing hormone agonist (GnRH-a), and more recently, a GnRH antagonist.
AIMS: We report a case of a 37 year old treated using the GnRH antagonist in a second completed cycle of IVF.
METHODS: IVF was performed for primary infertility of 5-year duration due to frozen pelvis secondary to endometriosis.
RESULTS: Following controlled ovarian hyperstimulation, oocyte recovery and fertilization, cleavage and transfer of two zygotes, a pregnancy established. A twin gestation was diagnosed at 7-weeks scan and pregnancy ended with the delivery of twin girls by emergency caesarean section.
CONCLUSION: This is a first report of a delivery following IVF using the antagonist protocol in Ireland. Such therapy is patient friendly and its use should be introduced on a larger scale in clinical practice.
AIMS: We report a case of a 37 year old treated using the GnRH antagonist in a second completed cycle of IVF.
METHODS: IVF was performed for primary infertility of 5-year duration due to frozen pelvis secondary to endometriosis.
RESULTS: Following controlled ovarian hyperstimulation, oocyte recovery and fertilization, cleavage and transfer of two zygotes, a pregnancy established. A twin gestation was diagnosed at 7-weeks scan and pregnancy ended with the delivery of twin girls by emergency caesarean section.
CONCLUSION: This is a first report of a delivery following IVF using the antagonist protocol in Ireland. Such therapy is patient friendly and its use should be introduced on a larger scale in clinical practice.